Electronic health record (EHR) documentation seen in primary care does not accurately reflect menopause symptom burden, and ...

The Indian pharmaceutical sector is set for a mixed quarter, with slow growth expected in the branded formulations, according to the Systematix Institutional Equities report. Analysts predict a median ...

While the satire is well-timed given the euphoria that currently engulfs the IPO markets in India, the matter of a company going public is a more serious one and requires much deliberation by its ...

To enhance patient outcomes and increased trial success, Convert Pharma is leveraging companion AI- and genetic biomarkers, a ...